NCT03496168View on ClinicalTrials.gov

Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

November 9, 2023

Study Completion Date

November 9, 2023

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

mavacamten

mavacamten capsules

Trial Locations (4)

27710

Local Institution - 0004, Durham

85259

Local Institution - 0003, Scottsdale

97239

Local Institution - 0002, Portland

06520-8017

Local Institution - 0001, New Haven

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY